<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: University of Texas M. D. Anderson Cancer Center in the news</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress provides the latest news from University of Texas M. D. Anderson Cancer Center</description>

 <item>
     <title>Scientists catch EGFR passing a crucial message to cancer-promoting protein</title>
   	 <description>Researchers have discovered and mapped the signaling network between two previously unconnected proteins, exposing a link that, if broken, could cut off cancer cell growth at its starting point.</description>
	  <link>http://medicalxpress.com/news/2013-06-scientists-egfr-crucial-message-cancer-promoting.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 18 Jun 2013 16:20:19 EST</pubDate>
	 <guid isPermaLink="false">news290791210</guid>
	 
</item>
<item>
     <title>MET protein levels show promise as biomarker for aggressive colon cancer</title>
   	 <description>MET protein levels correlate strongly with epithelial-mesenchymal transition (EMT) phenotype, a treatment-resistant type of colorectal cancer and may be used as a surrogate biomarker, according to new research from The University of Texas MD Anderson Cancer Center.</description>
	  <link>http://medicalxpress.com/news/2013-06-met-protein-biomarker-aggressive-colon.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 04 Jun 2013 07:26:26 EST</pubDate>
	 <guid isPermaLink="false">news289549579</guid>
	 
</item>
<item>
     <title>Bevacizumab offers no benefit for newly diagnosed glioblastoma, study finds</title>
   	 <description>The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to research led by researchers at The University of Texas MD Anderson Cancer Center.</description>
	  <link>http://medicalxpress.com/news/2013-06-bevacizumab-benefit-newly-glioblastoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 02 Jun 2013 06:30:01 EST</pubDate>
	 <guid isPermaLink="false">news289371734</guid>
	 
</item>
<item>
     <title>Test helps target glioblastoma patients most likely to benefit from bevacizumab</title>
   	 <description>A new test may help identify newly diagnosed glioblastoma patients more likely to benefit from bevacizumab (Avastin), according to new research from The University of Texas MD Anderson Cancer Center.</description>
	  <link>http://medicalxpress.com/news/2013-06-glioblastoma-patients-benefit-bevacizumab.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 02 Jun 2013 06:20:01 EST</pubDate>
	 <guid isPermaLink="false">news289371711</guid>
	 
</item>
<item>
     <title>Study finds glioblastoma patients treated with bevacizumab experience reduced cognitive function and quality of life</title>
   	 <description>Many glioblastoma patients treated with bevacizumab (Avastin) have significant deterioration in neurocognitive function, symptoms and quality of life. Not only that, the changes often predict treatment outcomes, according to new research from The University of Texas MD Anderson Cancer Center.</description>
	  <link>http://medicalxpress.com/news/2013-05-glioblastoma-patients-bevacizumab-cognitive-function.html</link>
	 <category>Cancer</category>
	 <pubDate>Sat, 01 Jun 2013 00:00:01 EST</pubDate>
	 <guid isPermaLink="false">news289223085</guid>
	 
</item>
<item>
     <title>When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs</title>
   	 <description>Even while being dragged to its destruction inside a cell, a cancer-promoting growth factor receptor fires away, sending signals that thwart the development of tumor-suppressing microRNAs (miRNAs) before it's dissolved, researchers reported in an early online publication at Nature.</description>
	  <link>http://medicalxpress.com/news/2013-05-oxygen-short-egfr-maturation-cancer-fighting.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 23 May 2013 16:30:07 EST</pubDate>
	 <guid isPermaLink="false">news288544056</guid>
	 
</item>
<item>
     <title>Body mass index of low income African-Americans linked to proximity of fast food restaurants</title>
   	 <description>African-American adults living closer to a fast food restaurant had a higher body mass index (BMI) than those who lived further away from fast food, according to researchers at The University of Texas MD Anderson Cancer Center, and this association was particularly strong among those with a lower income.</description>
	  <link>http://medicalxpress.com/news/2013-05-body-mass-index-income-african-americans.html</link>
	 <category>Health</category>
	 <pubDate>Thu, 16 May 2013 16:14:37 EST</pubDate>
	 <guid isPermaLink="false">news287939667</guid>
	 
</item>
<item>
     <title>Study finds key protein for firing up central nervous system inflammation</title>
   	 <description>Scientists have identified an influential link in a chain of events that leads to autoimmune inflammation of the central nervous system in a mouse model of multiple sclerosis (MS).</description>
	  <link>http://medicalxpress.com/news/2013-05-key-protein-central-nervous-inflammation.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 02 May 2013 09:41:12 EST</pubDate>
	 <guid isPermaLink="false">news286706459</guid>
	 
</item>
<item>
     <title>Study finds key to calling back-up help when tumor-fighter p53 goes down</title>
   	 <description>Tumor suppression, the family business of the sibling genes p53, p63 and p73, is undermined from within by the split personalities of p63 and p73, which each produce protein forms that not only block the work of the other two genes but also shut down its own cancer-stifling fraternal twin.</description>
	  <link>http://medicalxpress.com/news/2013-04-key-back-up-tumor-fighter-p53.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 08 Apr 2013 15:00:01 EST</pubDate>
	 <guid isPermaLink="false">news284644382</guid>
	 
</item>
<item>
     <title>Low levels of serum bilirubin spell higher lung cancer risk for male smokers</title>
   	 <description>Elevated levels of bilirubin in the blood get attention in the clinic because they often indicate that something has gone wrong with the liver. Now researchers have found that male smokers with low levels of the yellow-tinged chemical are at higher risk for lung cancer and dying from the disease.</description>
	  <link>http://medicalxpress.com/news/2013-04-serum-bilirubin-higher-lung-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 07 Apr 2013 13:00:06 EST</pubDate>
	 <guid isPermaLink="false">news284554793</guid>
	 
</item>
<item>
     <title>Varenicline reduces depressive mood, craving and reward value of cigarettes when smokers attempt to quit, study reports</title>
   	 <description>Smokers have a higher probability of quitting smoking and a better overall cessation experience when taking varenicline compared to bupropion and to placebo – unmedicated assisted smoking cessation –according to a study published in the journal JAMA Psychiatry.</description>
	  <link>http://medicalxpress.com/news/2013-03-varenicline-depressive-mood-craving-reward.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Wed, 27 Mar 2013 16:00:04 EST</pubDate>
	 <guid isPermaLink="false">news283614777</guid>
	 
</item>
<item>
     <title>Study shows confidence builds better exercise habits for cancer survivors</title>
   	 <description>Endometrial cancer survivors are more likely to complete physical activity, and for longer durations, when their daily self-efficacy is higher, according to a study published online in the journal Health Psychology – a publication of the American Psychology Association.</description>
	  <link>http://medicalxpress.com/news/2013-03-confidence-habits-cancer-survivors.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 08 Mar 2013 14:52:12 EST</pubDate>
	 <guid isPermaLink="false">news281976712</guid>
	 
</item>
<item>
     <title>Cancer vaccines self-sabotage, channel immune attack to injection site</title>
   	 <description>Cancer vaccines that attempt to stimulate an immune system assault fail because the killer T cells aimed at tumors instead find the vaccination site a more inviting target, scientists at The University of Texas MD Anderson Cancer Center report in Nature Medicine.</description>
	  <link>http://medicalxpress.com/news/2013-03-cancer-vaccines-self-sabotage-channel-immune.html</link>
	 <category>Medical research</category>
	 <pubDate>Sun, 03 Mar 2013 13:00:06 EST</pubDate>
	 <guid isPermaLink="false">news281520955</guid>
	 
</item>
<item>
     <title>Protein central to cancer stem cell formation provides new potential target</title>
   	 <description>Researchers have identified a pivotal protein in a cellular transformation that makes a cancer cell more resistant to treatment and more capable of growing and spreading, making it an inviting new target for drug development.</description>
	  <link>http://medicalxpress.com/news/2013-02-protein-central-cancer-stem-cell.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 13 Feb 2013 14:30:01 EST</pubDate>
	 <guid isPermaLink="false">news279987024</guid>
	 
</item>
<item>
     <title>Synthetic circuit allows dialing gene expression up or down in human cells</title>
   	 <description>Scientists who built a synthetic gene circuit that allowed for the precise tuning of a gene's expression in yeast have now refined this new research tool to work in human cells, according to research published online in Nature Communications.</description>
	  <link>http://medicalxpress.com/news/2013-02-synthetic-circuit-dialing-gene-human.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 12 Feb 2013 09:33:09 EST</pubDate>
	 <guid isPermaLink="false">news279883976</guid>
	 
</item>


</channel>
</rss>
